Roshon Michael, Khandhar Paras B, Biniwale Manoj, Ramanathan Rangasamy, Frazier T Patrick, Xu Feng, Zhang Linlin, Guan Xiangdong, Wenling Dai, Lambermont Bernard
Department of Emergency Medicine, Penrose-St. Francis Health Services, Colorado, Springs, CO, USA.
Pediatric Critical Care Medicine, Beaumont Children's Hospital, Royal Oak, MI, USA.
Med Devices (Auckl). 2024 Jan 23;17:37-45. doi: 10.2147/MDER.S433900. eCollection 2024.
Mechanical ventilation is a life-supporting intervention but is associated with known risks and complications. To improve the efficacy and safety profile of mechanical ventilation, manufacturers have developed advanced ventilator settings, modes, and alarm strategies to optimize ventilation for patient needs while avoiding complications. However, there is little real-world data published on the deployment of ventilator technology. The main objective of this study was to assess the clinical safety and performance of the Puritan Bennett™ 980 Ventilator System (PB980) using real-world clinical data collected from a diverse, global patient population.
This was a multi-center, post-market registry study that included nine sites: four in the United States of America, one in Europe, and four in China. Patients were enrolled into the registry if they were intended to be treated with a PB980. Data collection began at the start of ventilation and continued until extubation off the ventilator or up to seven days of ventilation, whichever occurred first. Subjects were divided by age into three categories: infants (0-365 days), pediatric (1-17 years), and adult (18 years and older). The primary outcome was device-related complication rate.
Two-hundred-and-eleven subjects were enrolled (41 infants, 48 pediatric, and 122 adults). Sixteen deaths, unrelated to device deficiency, occurred during the data collection timeframe (relative frequency: 7.58, 95% CI: 4.40, 12.0). Only one device-related adverse event was reported (relative frequency: 0.47% 95% CI: 0.01%, 2.61%).
Ventilation by the PB980 was delivered safely in this multi-center observational study, which included a diverse sample of patients with broad ventilatory needs.
机械通气是一种维持生命的干预措施,但存在已知风险和并发症。为提高机械通气的有效性和安全性,制造商开发了先进的呼吸机设置、模式和报警策略,以根据患者需求优化通气,同时避免并发症。然而,关于呼吸机技术应用的真实世界数据鲜有发表。本研究的主要目的是利用从全球不同患者群体收集的真实世界临床数据,评估伟康(Puritan Bennett™)980呼吸机系统(PB980)的临床安全性和性能。
这是一项多中心上市后注册研究,包括九个地点:美国四个、欧洲一个、中国四个。如果患者拟使用PB980进行治疗,则将其纳入注册研究。数据收集从通气开始时启动,持续至脱机拔管或通气7天(以先发生者为准)。受试者按年龄分为三类:婴儿(0 - 365天)、儿童(1 - 17岁)和成人(18岁及以上)。主要结局是与设备相关的并发症发生率。
共纳入211名受试者(41名婴儿、48名儿童和122名成人)。在数据收集期间发生了16例与设备缺陷无关的死亡(相对频率:7.58,95%置信区间:4.40,12.0)。仅报告了1例与设备相关的不良事件(相对频率:0.47%,95%置信区间:0.01%,2.61%)。
在这项多中心观察性研究中,PB980通气在各类有广泛通气需求的患者样本中安全实施。